drugset / Trial / NCT01357837
Assessment of GRT6005 in Painful Osteoarthritis of the Knee
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the trial is to determine whether GRT6005 is effective in patients with pain due to osteoarthritis of the knee.
Timeline
- Start
- 2011-05
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cebranopadol | Small molecule | 75 ug | Oral |
| Subject | Cebranopadol | Small molecule | 200 ug | Oral |
| Subject | Cebranopadol | Small molecule | 400 ug | Oral |